Conference Details

2008 Best Practices in Primary Care 9/19/2008

Hyatt Regency Phoenix
122 N. Second Street
Phoenix , AZ 85004
Phone: 602-252-1234

Who Should Attend

All primary care clinicians (physicians, physician assistants, and nurse practitioners) who are active in patient care.

Agenda

9/19/2008 6:30 am - 7:30 am Registration and Complimentary Continental Breakfast 7:30 am - 12:00 pm Sessions 1, 2, & 3 (each session followed by a 10-15 minute break) 12:00 pm - 12:30 pm Complimentary Lunch 12:30 pm - 6:15 pm Sessions 4, 5, 6, & 7 (each session followed by a 5-15 minute break)

Venue Information

Meeting Room: Regency Ballroom

Parking: Guests park in the city-owned Regency Parking Garage located on the south side of the hotel on the corner of 2nd Street and Adams Street. Self parking has a maximum daily rate of $10. Overnight self parking is $16. Valet parking has a maximum daily rate as well as overnight rate of $23.

A limited number of rooms have been reserved at the Hyatt Regency Phoenix at a rate of $179 per night. For reservations, call 602-252-1234 and mention the Primary Care Education Network room block. Reservations must be made by August 18, 2008 in order to receive the discounted rate.

Accreditation

ACCME
Primary Care Network, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Primary Care Network designates this educational activity for a maximum of 9.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AAFP
This activity has been reviewed and is acceptable for up to 9.25 Prescribed credits by the American Academy of Family Physicians.

AANP
This program has been approved for 9.25 contact hours of continuing education (which includes 4.66 hours of pharmacology) by the American Academy of Nurse Practitioners. Program ID 0809410.

AAPA
AAPA accepts Category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA Category 1 CME credit for the PRA from organizations accredited by ACCME.

Topics

Rheumatoid Arthritis   The Triangle of Treatment: Taking a Team Approach to Managing Rheumatoid Arthritis Overview Rheumatoid arthritis (RA) is a complex immunologic and chronic inflammatory disease that affects more than 2 million people in the United States. Characterized by inflammation of the joints, periarticular bone resorption and cartilage destruction, RA is also an inherently aggressive, systemic disease that leaves patients vulnerable to comorbidities such as cardiovascular disease, osteoporosis, lymphoma, infection, and stroke. While primary care clinicians may not directly treat the disease long term, they are the first to come in contact with potential RA patients. Therefore it is important for all clinicians to be aware of the necessary steps in RA diagnostic and treatment modalities. Objectives Identify 3 early warning signs of rheumatoid arthritis (RA) Describe current and evolving treatment options for RA, and be alert to monitoring and side effects related to these therapies Faculty John R.P. Tesser, MD, FACP, FACR Rheumatologist Arizona Arthritis and Rheumatology Associates, P.C. Paradise Valley, AZ   Diabetes   Taking Control of Glycemia in Type 2 Diabetes Patients with Cardiovascular Risk Overview More than 20 million people in the United States are affected by diabetes, with 1.5 million new cases appearing each year. Of this population, nearly 65% will die from heart disease or stroke, a rate that is 4-times higher than in the non-diabetic population. Individualized and early glycemic control is critical in the prevention and management of diabetes and in reducing cardiovascular risk. This activity will expose attendees to the relationship between insulin resistance, type 2 diabetes, and the resulting cardiovascular risk in an effort to uncover effective treatment strategies and patient-based therapeutic options. Objectives Utilize appropriate glucose-lowering agents to reduce A1C to * 7.0% Minimize adverse events and cardiovascular risk associated with glycemic therapy by employing appropriate glucose, blood pressure, and serum cholesterol agents Faculty Stephen Clement, MD Associate Professor of Medicine Division of Endocrinology Georgetown University Medical Center Acting Chief, Division of Endocrinology Georgetown University Hospital Washington, DC Natasa Janicic-Kahric, MD, PhD Assistant Professor of Medicine Division of Endocrinology and Metabolism Georgetown University Hospital Washington, DC   Dyslipidemia   The Moving LDL Target: Getting Your Patients to Goal Overview The current use of lipid lowering therapy in clinical practice has fallen short of the recommendations of national guidelines. Clearly, not an easy venture when treating patients with dyslipidemia, many with multiple risk factors and many with resulting coronary events that may be preventable if patients were treated aggressively to meet the NCEP-ATP lll goals. This presentation will address the clinical challenges of goal attainment (lack of compliance, aggressive treatment by clinicians, not leaving patients 15 points from goals), and provide clinicians with the pathways and knowledge to help attain their patients to goal. Objectives Describe at least two challenges in treating dyslipidemia to NCEP-ATP III goals, implement strategies that will help to assess CHD risk accurately, and get patients to targeted goals Identify patients at increased risk for cardiovascular events and develop a treatment plan with at least 2 lipid lowering strategies, including the use of multiple therapies, which will help these patients achieve guideline-based targets taking into consideration current lifestyle and pharmacologic treatment options available thus reducing overall cardiovascular risk Faculty Benjamin J. Ansell, MD Assistant Professor of Internal Medicine University of California, Los Angeles (UCLA) School of Medicine Los Angeles, CA Daniel E. Diamond, MD, FAAFP Assistant Clinical Professor, Department of Family Medicine University of Washington School of Medicine Seattle, WA   Insomnia   Insomnia: New Directions in Evaluation and Treatment Overview Despite a high prevalence in the United States, insomnia remains underdiagnosed and undertreated. Extensive research has identified several factors that contribute to the inadequate treatment of insomnia, including the failure of patients to report insomnia to clinicians and clinician misperceptions about the risks associated with hypnotic medications. This program will address effective strategies for diagnosing and treating patients with insomnia. Objectives Identify risk factors, determine appropriate screening tools, and accurately diagnose insomnia Evaluate current and emerging nonpharmacologic and pharmacologic therapies for acute and chronic insomnia on the basis of efficacy and safety and apply this knowledge/skill with patients Faculty Joseph A. Lieberman III, MD, MPH Professor of Family Medicine Jefferson Medical College Thomas Jefferson University Associate Editor, Delaware Medical Journal Philadelphia, PA Thomas C. Neylan, MD University of California, San Francisco San Francisco, CA   Acne / Actinic Keratosis   More Than Skin Deep: Clinical Strategies for Acne Vulgaris and Actinic Keratosis Overview ÒMore Than Skin Deep: Clinical Strategies for Acne Vulgaris and Actinic KeratosisÓ is a continuing medical education program that aims to bridge some of the existing professional practice gaps that primary care clinicians may have regarding common dermatologic problems. This program will educate clinicians in the primary care setting about the prevalence, impact, diagnosis, and treatment of both acne vulgaris and actinic keratosis. Objectives Confidently diagnose patients presenting with the basic dermatologic conditions of acne vulgaris and actinic keratosis Identify the most commonly used treatments for acne vulgaris and actinic keratosis Faculty Seth Orlow, MD, PhD Chair, Department of Dermatology Samuel Weinberg Professor of Pediatric Dermatology Professor of Cell Biology and Pediatrics New York University School of Medicine New York, NY Andrea L. Zaenglein, MD Dermatologist Department of Dermatology Milton S. Hershey Medical Center Pennsylvania State University Hershey, PA   Rhinitis   Allergic Rhinitis and Its Comorbidities: A Serious Challenge to the Healthcare Professional Overview Allergic rhinitis (AR) is the most common allergic condition in the US, affecting nearly 40 million people. Although AR is associated with significant comorbidities, current therapies have proven only modestly successful. Allergic Rhinitis and Its Comorbidities: A Serious Challenge to the Health Care Professional will provide primary care physicians with practical, evidence-based solutions to the challenges of managing AR, with particular emphasis on finding effective treatments and ensuring patient compliance. Two nationally recognized allergy/immunology experts will lead each 75-minute presentation with 60 minutes of didactic lectures and case history presentation, and a 15-minute question-and-answer session. Interactive discussion and a dynamic audience response system will also be integrated into the session. Objectives Describe key clinical characteristics of allergic rhinitis, its associated comorbidities, and its impact on patient health and quality of life Identify barriers to treatment success of allergic rhinitis (treatment-related, physician-related, and patient-related barriers) and adequate control of symptoms, and devise strategies for overcoming those barriers Faculty Anthony Montanaro, MD Oregon Health and Science University Portland, Oregon Eli Meltzer, MD Clinical Professor of Pediatrics University of California, San Diego, School of Medicine Co-Director Allergy and Asthma Medical Group and Research Center San Diego, California   Mood Disorders   Managing Mood and Anxiety Disorders in Primary Care Practice: A Focus on Complex and Difficult-to-Treat Patients Overview Bipolar disorder (BD) and major depressive disorder (MDD) are two of the most prevalent psychiatric disorders in adults. These conditions are associated with overlapping disorders of mood including anxiety and depression; differentiating the two disorders can be difficult and can lead to misdiagnosis and mismanagement. This activity will focus on practical approaches to the diagnosis and management of the Òdifficult-to-treatÓ patient presenting with depression associated with MDD and BD. Objectives Recognize overlapping symptomatology and comorbid psychiatric disorders that can complicate the differential diagnosis of depression Design and implement practical strategies to diagnosis and manage the difficult-to-treat patient with depression associated with major depressive disorder and bipolar disorder Faculty Larry Culpepper, MD, MPH Professor of Family Medicine Department of Family Medicine Chair Boston University School of Medicine Chief of Family Practice Boston Medical Center Boston, MA

Primary Care Network complies with the Americans with Disabilities Act. If you require special services to support your participation in this continuing education program, contact us directly
at 877-594-1770.

Overnight accommodations and parking fees are the responsibility of the participant of this CME activity. Please contact the hotel hosting this program to book overnight accommodations.